Palladyne AI reported headline growth that looks dramatic: second-quarter revenue rose 470% year over year and 63% sequentially to $5.783 million. Palladyne AI Corp. (NASDAQ:PDYN) ended June with $24.6 million of backlog, up 43% during the quarter after roughly $13 million of new contract awards, net of revenue recognized. Management expects most of that backlog to become revenue over the next 12 to 18 months and reiterated 2026 revenue guidance of $24 million to $27 million, or 357% to 415% growth.
Copyright: ralwel / 123RF Stock Photo
The comparison needs an important qualification. Palladyne said the increase came from acquisitions as well as organic growth. Its 10-Q says second-quarter product revenue was derived mainly from businesses acquired in November 2025, while engineering-services revenue came from one acquired business. Revenue consisted of hardware products, development contracts, and engineering services; the filing explicitly says Palladyne had generated no software-product revenue to date. The quarter therefore does not yet demonstrate scaled sales of its proprietary autonomy software.
The bull case is that backlog and defense awards provide a bridge to that commercialization. Programs involving SwarmOS, Gremlin-X, BRAIN flight computers, and Air Force development work may deepen customer relationships. But award values do not become revenue immediately, and fixed-price development work can produce weak margins if actual costs exceed estimates. Palladyne separately put total estimated contract value at $30.9 million, but that broader figure includes unexercised options and should not be confused with firm backlog.
The loss profile remains severe. Operating loss widened to $13.413 million from $8.094 million a year earlier, and net loss reached $12.326 million. Palladyne held $33.774 million of cash and equivalents plus $9.972 million of marketable securities, totaling $43.746 million. Its reiterated full-year operating-cash-burn outlook was $32 million to $36 million; the company defines that measure as operating cash used plus capital expenditures.
Dilution is part of the financing risk. Palladyne sold 2,531,336 shares through its at-the-market program during the first half for $17.8 million of gross proceeds, and the 10-Q says equity offerings have been its main source of liquidity.
Hedge-fund ownership slipped to 14 funds at June 30 from 15 in Q1, although Marshall Wace increased its position 196% to 281,789 shares. At the August 14 settlement, 7,922,145 shares were sold short, equal to 7.72 days of average volume. The backlog makes the growth story credible; cash conversion, software revenue, margins, and future share issuance will determine whether it becomes durable. That distinction is central for a company still funding large losses.
READ NEXT: NVIDIA (NVDA): What Foxconn and Super Micro Are Telling Us about the AI Boom and Pony AI Is Scaling Robotaxis Fast—Can the Stock Reach BofA’s $17 Target?
Follow Insider Monkey on Google News.
